CME Group (CME) Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CME shares.
View CME analyst ratings or view top-rated stocks.

10 equities research analysts have issued 1 year target prices for CME Group's stock. Their CME share price forecasts range from $173.00 to $250.00. On average, they expect the company's share price to reach $211.00 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $168.16 at the start of the year. Since then, CME stock has increased by 20.0% and is now trading at $201.72.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our CME earnings forecast.

CME Group will be holding an earnings conference call on Wednesday, October 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) announced its earnings results on Wednesday, July, 26th. The financial services provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.10. The financial services provider earned $1.36 billion during the quarter, compared to analysts' expectations of $1.34 billion. CME Group had a trailing twelve-month return on equity of 11.30% and a net margin of 56.88%. The company's quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.97 EPS.
Read the conference call transcript.

CME Group announced a quarterly dividend on Thursday, August 3rd. Investors of record on Friday, September 8th will be given a dividend of $1.10 per share on Wednesday, September 27th. This represents a $4.40 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date is Thursday, September 7th.
Read our dividend analysis for CME.

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), TrueShares Low Volatility Equity Income ETF (DIVZ), Capital Link Global Fintech Leaders ETF (KOIN), VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK).

CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.14%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 53.72%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 47.93% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by many different retail and institutional investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (152.73%), BlackRock Inc. (6.56%), State Street Corp (4.43%), Capital International Investors (3.89%), Capital World Investors (3.67%) and Capital Research Global Investors (2.55%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CME stock can currently be purchased for approximately $201.72.

CME Group (NASDAQ:CME) has a market capitalization of $72.57 billion and generates $5.02 billion in revenue each year. The financial services provider earns $2.69 billion in net income (profit) each year or $8.19 on an earnings per share basis.

The company employs 3,460 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for the company is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at info@cmegroup.com, or via fax at 312-466-4410.